Anna Berkenblit, MD, MMSc (@aberkenblit) 's Twitter Profile
Anna Berkenblit, MD, MMSc

@aberkenblit

Chief Scientific & Medical Officer @PanCAN 💜 | Biotech Executive | Oncologist | Drug Developer

ID: 1366910234

calendar_today20-04-2013 12:22:29

130 Tweet

166 Followers

299 Following

Mike Pishvaian (@mpishvaian) 's Twitter Profile Photo

PanCAN Optum Penn Medicine MD Univ. of Pennsylvania Department of Cancer Biology Penn Medicine Johns Hopkins University Johns Hopkins Medicine I can't even begin to express what an honor and a privilege it is to work with this group, under PanCAN 's leadership, and following the path of many amazing predecessors 🙏Thank you a million times over for the opportunity

Italian Pancreatic Cancer Community I-PCC (@italianpcc) 's Twitter Profile Photo

📢 Global update on #PancreaticCancer from the WPCC W P C C member call! Dr. Anna Berkenblit PanCAN shared key insights: 🔬 Precision medicine 🧬 KRAS inhibitors & vaccines 📊 #ASCO2025 updates 🧪 Early detection tools Here the full presentation 👇 i-pcc.org/news/state-of-…

Anna Berkenblit, MD, MMSc (@aberkenblit) 's Twitter Profile Photo

I’m on Episode 2 of the all-new PancChat Podcast! 🎙️💬 Join Dr. Allyson Ocean and me as we talk with host Alisyn Camerota about the current state of #pancreaticcancer treatment and research. PanCAN Let's Win Pancreatic Cancer 💜 share.transistor.fm/s/846bf15a

Let's Win Pancreatic Cancer 💜 (@letswinpc) 's Twitter Profile Photo

🎙️ New #PancChat episode! Host Alisyn Camerota speaks with Dr. Anna Berkenblit, MD, MMSc, Chief Scientific & Medical Officer at PanCAN, and @DrAllysonOcean of Weill Cornell Medicine, co-founder of Let's Win and chair of our Scientific Advisory Board. share.transistor.fm/s/846bf15a

PanCAN (@pancan) 's Twitter Profile Photo

PanCAN volunteers recently had the opportunity to tour the Rogel and Blondy Center for Pancreatic Cancer at U-M Rogel Cancer Center and connect with the incredible team driving progress forward. 🥼🤝 Rogel and Blondy Center for Pancreatic Cancer shared, “Had the privilege of welcoming several amazing & dedicated

PanCAN volunteers recently had the opportunity to tour the Rogel and Blondy Center for Pancreatic Cancer at <a href="/UMRogelCancer/">U-M Rogel Cancer Center</a> and connect with the incredible team driving progress forward. 🥼🤝

<a href="/UMICHpancreas/">Rogel and Blondy Center for Pancreatic Cancer</a> shared, “Had the privilege of welcoming several amazing &amp; dedicated
PanCAN (@pancan) 's Twitter Profile Photo

In Episode 2 of the PancChat Podcast, host Alisyn Camerota sits down with Dr. @ABerkenblit and @DrAllysonOcean to discuss how advocacy, research, and early detection are shaping the future of #pancreaticcancer care. 💜🎙️💬 Listen now on all major podcast platforms, including

Allison Rosenzweig (@arosenzweig19) 's Twitter Profile Photo

It was an honor to co-author this Journal of Participatory Medicine article with my PanCAN colleagues, following through on our promise to patients to publish results from their participation in our Registry 💜 jopm.jmir.org/2025/1/e65046/

Anna Berkenblit, MD, MMSc (@aberkenblit) 's Twitter Profile Photo

I’m so excited about RAS inhibitors! 🧬🔬 Listen to Episode 2 of the all-new PancChat Podcast, where I discuss this and more with @DrAllysonOcean and host Alisyn Camerota. share.transistor.fm/s/846bf15a PanCAN Let's Win Pancreatic Cancer 💜

Anna Berkenblit, MD, MMSc (@aberkenblit) 's Twitter Profile Photo

Thrilled to see this Gastroenterology paper published by Drs Suresh Chari, Ziding Feng, & colleagues, funded in part by PanCAN & incl. my colleague Lynn Matrisian. Important findings about new-onset diabetes & #pancreaticcancer, with results varying by race. gastrojournal.org/article/S0016-…

Thrilled to see this <a href="/AGA_Gastro/">Gastroenterology</a> paper published by Drs Suresh Chari, Ziding Feng, &amp; colleagues, funded in part by <a href="/PanCAN/">PanCAN</a> &amp; incl. my colleague <a href="/LynnMatrisian/">Lynn Matrisian</a>. Important findings about new-onset diabetes &amp; #pancreaticcancer, with results varying by race. gastrojournal.org/article/S0016-…
Anna Berkenblit, MD, MMSc (@aberkenblit) 's Twitter Profile Photo

I’m grateful to the patients who shared their experiences through PanCAN’s Patient Registry and proud to contribute data that can help shape better outcomes.

PanCAN (@pancan) 's Twitter Profile Photo

Precision medicine is gaining momentum in #pancreaticcancer. By identifying unique features in a patient’s tumor — like rare FGFR2 gene fusions — more personalized treatment options are becoming possible. 🧬🔬 An innovative new clinical trial is now making it easier for patients

Precision medicine is gaining momentum in #pancreaticcancer. By identifying unique features in a patient’s tumor — like rare FGFR2 gene fusions — more personalized treatment options are becoming possible. 🧬🔬

An innovative new clinical trial is now making it easier for patients
Allison Rosenzweig (@arosenzweig19) 's Twitter Profile Photo

Great writeup by Anna Berkenblit, MD, MMSc PanCAN on precision medicine approaches in #pancreaticcancer, including Dr Roychowdhury's The James novel telemedicine-based clinical trial targeting FGFR2 (which happens to have been the focus of my PhD work, too!)

Anna Berkenblit, MD, MMSc (@aberkenblit) 's Twitter Profile Photo

Had the privilege of meeting Dr. Sameek Roychowdhury (The James) at #ASCO25. He’s leading an innovative clinical trial for FGFR2+ #pancreaticcancer that lets patients enroll where they already receive care. Learn more: pancan.org/news/research-…

Let's Win Pancreatic Cancer 💜 (@letswinpc) 's Twitter Profile Photo

Episode 3 of the Let's Win and PanCAN's #PancChat Podcast is live! Listen as Dr. Anirban Maitra (Anirban Maitra) of @MDAnderson NYU Langone Health and Dr. Michael Goggins of Johns Hopkins Medicine discuss #PancreaticCancer Risk Factors with Alisyn Camerota. share.transistor.fm/s/7c8193db